Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Female patients of any ethnicity who are scheduled to have surgery to remove ovarian cancer tumours may be considered for this trial.
- Participants must be 18 years of age or older.
- There must be a medical suspicion or confirmed diagnosis of ovarian cancer, and surgery for tumour removal must already be planned.
- Participants must be able to understand the study and be willing to sign a written consent form.
- The cancer must be confirmed by laboratory testing as a specific type of ovarian, fallopian tube, or peritoneal cancer (types include serous, mucinous, clear cell, endometrioid, undifferentiated, mixed, or transitional cell).
- Women who could potentially become pregnant must have a negative blood pregnancy test taken no more than 2 weeks before joining the study.
- For the purpose of this trial, a woman is considered potentially able to become pregnant unless she has had her uterus or both ovaries surgically removed, or has gone through natural menopause with no periods for at least 12 months in a row.
Who may not be able to join:
- People who are not able to give their own informed consent to participate (for example, those who require another person to make medical decisions on their behalf).
- Vulnerable groups such as prisoners.
- People under 18 years of age.
- Women who are pregnant.
- People whose final laboratory results after surgery do not confirm an invasive cancer of the ovary, fallopian tube, or peritoneum.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sarah Adams, MD, UNM Comprehensive Cancer Center
Phone: (505) 925-0461
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Collect ascites fluid obtained from ovarian cancer patients during cytoreductive surgery or paracentesis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.